The global Cancer Diagnostics Market, valued at US$ 121.8 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2035, surpassing US$ 292.4 billion by 2035. Cancer diagnostics encompass imaging, biopsy, biomarkers, and molecular testing for detecting cancers like breast, lung, and colorectal. The market is driven by rising cancer incidence,...